853 studies found for:    Huntington's Disease
Show Display Options
Rank Status Study
21 Completed Premanifest Huntington's Disease Extension Study II: Creatine Safety & Tolerability
Condition: Huntington's Disease
Intervention: Drug: Creatine monohydrate
22 Unknown  Ursodiol in Huntington's Disease
Condition: Huntington Disease
Interventions: Drug: ursodiol;   Drug: placebo
23 Not yet recruiting PINS Stimulator System for Deep Brain Stimulation in Huntington's Disease
Condition: Huntington's Disease
Intervention: Device: Deep Brain Stimulation
24 Unknown  Bioavailability of Ubiquinol in Huntington Disease
Condition: Huntington Disease
Intervention: Dietary Supplement: ubiquinol
25 Active, not recruiting Effects of EGCG (Epigallocatechin Gallate) in Huntington's Disease (ETON-Study)
Condition: Huntington Disease
Interventions: Drug: (2)-epigallocatechin-3-gallate (EGCG);   Drug: Placebo
26 Completed Effects of Lithium and Divalproex`on Brain-Derived Neurotrophic Factor in Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: Lithium;   Drug: Divalproex
27 Recruiting Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Condition: Huntington's Disease
Interventions: Drug: Creatine Monohydrate;   Drug: Placebo
28 Completed Deep Brain Stimulation of the Globus Pallidus in Huntington's Disease
Condition: Huntington's Disease
Intervention: Procedure: Stimulation
29 Completed A Study of Treatment With ACR16 in Patients With Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: ACR16;   Drug: Placebo
30 Recruiting Neuroleptic and Huntington Disease Comparison of : Olanzapine, la Tetrabenazine and Tiapride
Condition: Huntington Disease
Interventions: Drug: Olanzapine;   Drug: Xenazine;   Drug: Tiapridal
31 Completed
Has Results
Creatine Safety & Tolerability in Huntington's Disease
Condition: Huntington's Disease (HD)
Intervention: Drug: Creatine monohydrate
32 Completed A Study of ACR16 for the Treatment of Patients With Huntington's Disease
Condition: Huntington Disease
Interventions: Drug: ACR16 10 mg;   Drug: ACR16 22.5 mg;   Drug: ACR16 45 mg;   Other: Placebo
33 Recruiting REGISTRY-JHD - an Observational Study of the European Huntington's Disease Network (EHDN)
Condition: Huntington Disease, Juvenile
Intervention:
34 Completed Neuroprotection by Cannabinoids in Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD);   Drug: Placebo
35 Completed Safety and Tolerability Study of Phenylbutyrate in Huntington's Disease (PHEND-HD)
Condition: Huntington's Disease
Intervention: Drug: sodium phenylbutyrate
36 Completed Impact of Xenazine(Tetrabenazine)on Gait and Functional Activity in Individuals With Huntington's Disease
Condition: Huntington's Disease
Intervention:
37 Completed Making Sense of a Positive Genetic Test Result for Huntington Disease
Condition: Huntington Disease
Intervention:
38 Completed
Has Results
Pilot Study of Minocycline in Huntington's Disease
Condition: Huntington Disease
Interventions: Drug: minocycline;   Drug: Matching placebo
39 Completed TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease
Condition: Huntington Disease
Intervention: Drug: Ethyl-EPA  (Miraxion™)
40 Recruiting Study Evaluating The Safety, Tolerability And Brain Function Of 2 Doses Of PF-0254920 In Subjects With Early Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: PF-02545920;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years